Working Groups

• Anti-inflammatory drug use
• Clinical outcomes
• Dietary patterns
• Environmental exposures
• Functional assays
• Gender differences in bladder cancer risk factors
• Genome wide association studies (GWAS)
• Hair dye use and bladder cancer risk in females
• Molecular genetic alterations in bladder tumours
• Occupational exposures
• Pathology criteria
• Polymorphisms in carcinogen metabolizing genes
• Polymorphisms in cell cycle, apoptosis, and transcription factors
• Polymorphisms in DNA repair
• Tumour subgroup by histology, aggressiveness and "in situ" component